Phase I dose-escalation and pharmacokinetic study of temozolomide (SCH 52365) for refractory or relapsing malignancies

M. Brada(Institute of Cancer Research), David L. Cutler(AIL Research (United States))
British Journal of Cancer
October 29, 1999
10.1038/sj.bjc.6690802
Cited by 208

Related Papers

No related papers found

Powered by citation graph analysis